Slc6a8 Mouse (-)-epigallocatechin 3-gallate multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC6A8 mRNA CTD PMID:22079256 Slc6a8 Mouse (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC6A8 mRNA CTD PMID:36331819 Slc6a8 Mouse 1,2,4-trimethylbenzene decreases expression ISO Slc6a8 (Rattus norvegicus) 6480464 pseudocumene results in decreased expression of SLC6A8 protein CTD PMID:17337753 Slc6a8 Mouse 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SLC6A8 mRNA CTD PMID:22206623 Slc6a8 Mouse 17alpha-ethynylestradiol decreases expression ISO Slc6a8 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of SLC6A8 mRNA CTD PMID:17557909 Slc6a8 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC6A8 mRNA CTD PMID:21570461 and PMID:26377647 Slc6a8 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc6a8 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC6A8 mRNA CTD PMID:34747641 Slc6a8 Mouse 2,4-dinitrotoluene affects expression ISO Slc6a8 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of SLC6A8 mRNA CTD PMID:21346803 Slc6a8 Mouse 2,6-dinitrotoluene affects expression ISO Slc6a8 (Rattus norvegicus) 6480464 2 and 6-dinitrotoluene affects the expression of SLC6A8 mRNA CTD PMID:21346803 Slc6a8 Mouse 2-methylcholine affects expression ISO SLC6A8 (Homo sapiens) 6480464 beta-methylcholine affects the expression of SLC6A8 mRNA CTD PMID:21179406 Slc6a8 Mouse 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SLC6A8 mRNA CTD PMID:20188158 Slc6a8 Mouse 3-chloropropane-1,2-diol increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in increased expression of SLC6A8 mRNA CTD PMID:28522335 Slc6a8 Mouse 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of SLC6A8 mRNA CTD PMID:28973697 Slc6a8 Mouse 5-aza-2'-deoxycytidine increases expression ISO SLC6A8 (Homo sapiens) 6480464 Decitabine results in increased expression of SLC6A8 mRNA CTD PMID:17908484 Slc6a8 Mouse 6-propyl-2-thiouracil decreases expression ISO Slc6a8 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of SLC6A8 mRNA CTD PMID:24780913 Slc6a8 Mouse acetamide increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 acetamide results in increased expression of SLC6A8 mRNA CTD PMID:31881176 Slc6a8 Mouse actinomycin D multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of SLC6A8 mRNA CTD PMID:38460933 Slc6a8 Mouse aflatoxin B1 increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of SLC6A8 mRNA CTD PMID:22484513 more ... Slc6a8 Mouse all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of SLC6A8 mRNA CTD PMID:16604517 Slc6a8 Mouse all-trans-retinoic acid increases expression ISO SLC6A8 (Homo sapiens) 6480464 Tretinoin results in increased expression of SLC6A8 mRNA CTD PMID:33167477 Slc6a8 Mouse all-trans-retinoic acid increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 Tretinoin results in increased expression of SLC6A8 mRNA CTD PMID:20488242 Slc6a8 Mouse all-trans-retinoic acid decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Tretinoin results in decreased expression of SLC6A8 mRNA CTD PMID:21934132 Slc6a8 Mouse ammonia affects expression ISO SLC6A8 (Homo sapiens) 6480464 Ammonia affects the expression of SLC6A8 protein CTD PMID:20227315 Slc6a8 Mouse ammonium chloride affects expression ISO Slc6a8 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of SLC6A8 mRNA CTD PMID:16483693 Slc6a8 Mouse ampicillin increases expression ISO SLC6A8 (Homo sapiens) 6480464 Ampicillin results in increased expression of SLC6A8 mRNA CTD PMID:21632981 Slc6a8 Mouse arsane multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC6A8 mRNA CTD PMID:32525701 Slc6a8 Mouse arsenic atom multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC6A8 mRNA CTD PMID:32525701 Slc6a8 Mouse arsenous acid increases expression ISO SLC6A8 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of SLC6A8 mRNA CTD PMID:20458559 Slc6a8 Mouse atenolol decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Atenolol results in decreased expression of SLC6A8 mRNA CTD PMID:19915711 Slc6a8 Mouse benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of SLC6A8 mRNA CTD PMID:22228805 Slc6a8 Mouse benzo[a]pyrene increases methylation ISO SLC6A8 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SLC6A8 5' UTR more ... CTD PMID:27901495 Slc6a8 Mouse benzo[a]pyrene diol epoxide I increases expression ISO SLC6A8 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 Slc6a8 Mouse bisphenol A increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of SLC6A8 mRNA CTD PMID:25181051 Slc6a8 Mouse bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC6A8 mRNA CTD PMID:35479511 Slc6a8 Mouse bisphenol A affects expression ISO SLC6A8 (Homo sapiens) 6480464 bisphenol A affects the expression of SLC6A8 mRNA CTD PMID:30903817 Slc6a8 Mouse bisphenol A increases methylation ISO Slc6a8 (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of SLC6A8 gene CTD PMID:28505145 Slc6a8 Mouse butanal increases expression ISO SLC6A8 (Homo sapiens) 6480464 butyraldehyde results in increased expression of SLC6A8 mRNA CTD PMID:26079696 Slc6a8 Mouse C60 fullerene increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 fullerene C60 results in increased expression of SLC6A8 mRNA CTD PMID:19167457 Slc6a8 Mouse cadmium atom multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC6A8 mRNA CTD PMID:35301059 Slc6a8 Mouse cadmium dichloride decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of SLC6A8 mRNA CTD PMID:38568856 Slc6a8 Mouse cadmium dichloride multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC6A8 mRNA CTD PMID:35301059 Slc6a8 Mouse caffeine affects phosphorylation ISO SLC6A8 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of SLC6A8 protein CTD PMID:35688186 Slc6a8 Mouse captan increases expression EXP 6480464 Captan results in increased expression of SLC6A8 mRNA CTD PMID:31558096 Slc6a8 Mouse carbamazepine affects expression ISO SLC6A8 (Homo sapiens) 6480464 Carbamazepine affects the expression of SLC6A8 mRNA CTD PMID:25979313 Slc6a8 Mouse carbon nanotube increases expression EXP 6480464 Nanotubes and Carbon results in increased expression of SLC6A8 mRNA CTD PMID:25554681 Slc6a8 Mouse CGP 52608 multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC6A8 gene] CTD PMID:28238834 Slc6a8 Mouse chlorpyrifos decreases expression ISO Slc6a8 (Rattus norvegicus) 6480464 Chlorpyrifos results in decreased expression of SLC6A8 mRNA CTD PMID:17452286 Slc6a8 Mouse chlorpyrifos multiple interactions EXP 6480464 Chlorpyrifos promotes the reaction [Hemicholinium 3 binds to SLC6A8 protein] CTD PMID:33007016 Slc6a8 Mouse chlorpyrifos increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 Chlorpyrifos results in increased expression of SLC6A8 mRNA CTD PMID:18812211 Slc6a8 Mouse choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC6A8 mRNA CTD PMID:20938992 Slc6a8 Mouse chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of SLC6A8 mRNA CTD PMID:28472532 Slc6a8 Mouse cisplatin multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of SLC6A8 mRNA CTD PMID:21858171 Slc6a8 Mouse cisplatin increases expression ISO SLC6A8 (Homo sapiens) 6480464 Cisplatin results in increased expression of SLC6A8 mRNA CTD PMID:38498338 Slc6a8 Mouse copper atom increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 Copper results in increased expression of SLC6A8 mRNA CTD PMID:30556269 Slc6a8 Mouse copper(0) increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 Copper results in increased expression of SLC6A8 mRNA CTD PMID:30556269 Slc6a8 Mouse copper(II) sulfate decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of SLC6A8 mRNA CTD PMID:19549813 Slc6a8 Mouse cyclosporin A decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC6A8 mRNA CTD PMID:20106945 more ... Slc6a8 Mouse D-gluconic acid increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 gluconic acid results in increased expression of SLC6A8 mRNA CTD PMID:16556975 Slc6a8 Mouse diarsenic trioxide increases expression ISO SLC6A8 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of SLC6A8 mRNA CTD PMID:20458559 Slc6a8 Mouse diazinon increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 Diazinon results in increased expression of SLC6A8 mRNA CTD PMID:18812211 Slc6a8 Mouse Dibutyl phosphate affects expression ISO SLC6A8 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of SLC6A8 mRNA CTD PMID:37042841 Slc6a8 Mouse dicrotophos increases expression ISO SLC6A8 (Homo sapiens) 6480464 dicrotophos results in increased expression of SLC6A8 mRNA CTD PMID:28302478 Slc6a8 Mouse dieldrin increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 Dieldrin results in increased expression of SLC6A8 mRNA CTD PMID:18812211 Slc6a8 Mouse diflunisal increases expression EXP 6480464 Diflunisal results in increased expression of SLC6A8 mRNA CTD PMID:29901742 Slc6a8 Mouse dioxygen increases expression ISO SLC6A8 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of SLC6A8 mRNA CTD PMID:20042640 Slc6a8 Mouse dioxygen multiple interactions ISO Slc6a8 (Rattus norvegicus) 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of SLC6A8 mRNA CTD PMID:33729688 Slc6a8 Mouse diquat decreases expression EXP 6480464 Diquat results in decreased expression of SLC6A8 protein CTD PMID:36851058 Slc6a8 Mouse dorsomorphin multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Slc6a8 Mouse doxorubicin increases expression ISO SLC6A8 (Homo sapiens) 6480464 Doxorubicin results in increased expression of SLC6A8 mRNA CTD PMID:29803840 Slc6a8 Mouse elemental selenium increases expression ISO SLC6A8 (Homo sapiens) 6480464 Selenium results in increased expression of SLC6A8 mRNA CTD PMID:19244175 Slc6a8 Mouse entinostat decreases expression ISO SLC6A8 (Homo sapiens) 6480464 entinostat results in decreased expression of SLC6A8 mRNA CTD PMID:26272509 Slc6a8 Mouse entinostat multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 Slc6a8 Mouse epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of SLC6A8 mRNA CTD PMID:35436446 Slc6a8 Mouse folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC6A8 mRNA CTD PMID:20938992 Slc6a8 Mouse folpet increases expression EXP 6480464 folpet results in increased expression of SLC6A8 mRNA CTD PMID:31558096 Slc6a8 Mouse glyphosate increases expression EXP 6480464 Glyphosate results in increased expression of SLC6A8 mRNA CTD PMID:35897073 Slc6a8 Mouse graphite affects expression ISO Slc6a8 (Rattus norvegicus) 6480464 Graphite affects the expression of SLC6A8 mRNA CTD PMID:29933104 Slc6a8 Mouse hydrogen peroxide affects expression ISO SLC6A8 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of SLC6A8 mRNA CTD PMID:20044591 Slc6a8 Mouse L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC6A8 mRNA CTD PMID:20938992 Slc6a8 Mouse lead diacetate increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 lead acetate results in increased expression of SLC6A8 mRNA CTD PMID:11578147 Slc6a8 Mouse mercury dibromide decreases expression ISO SLC6A8 (Homo sapiens) 6480464 mercuric bromide results in decreased expression of SLC6A8 mRNA CTD PMID:26272509 Slc6a8 Mouse mercury dibromide multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 Slc6a8 Mouse methamphetamine increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of SLC6A8 mRNA CTD PMID:15644446 Slc6a8 Mouse methylmercury chloride decreases expression ISO SLC6A8 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of SLC6A8 mRNA CTD PMID:28001369 Slc6a8 Mouse N-ethyl-N-nitrosourea increases mutagenesis ISO Slc6a8 (Rattus norvegicus) 6480464 Ethylnitrosourea results in increased mutagenesis of SLC6A8 gene CTD PMID:16495775 Slc6a8 Mouse naphthalenes decreases expression ISO Slc6a8 (Rattus norvegicus) 6480464 Naphthalenes results in decreased expression of SLC6A8 protein CTD PMID:17337753 Slc6a8 Mouse Nutlin-3 multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of SLC6A8 mRNA CTD PMID:38460933 Slc6a8 Mouse orphenadrine affects expression ISO Slc6a8 (Rattus norvegicus) 6480464 Orphenadrine affects the expression of SLC6A8 mRNA CTD PMID:23665939 Slc6a8 Mouse ozone increases expression EXP 6480464 Ozone results in increased expression of SLC6A8 mRNA CTD PMID:33026818 Slc6a8 Mouse p-chloromercuribenzoic acid decreases expression ISO SLC6A8 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of SLC6A8 mRNA CTD PMID:26272509 Slc6a8 Mouse p-chloromercuribenzoic acid multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 Slc6a8 Mouse panobinostat multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 Slc6a8 Mouse panobinostat decreases expression ISO SLC6A8 (Homo sapiens) 6480464 panobinostat results in decreased expression of SLC6A8 mRNA CTD PMID:26272509 Slc6a8 Mouse paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SLC6A8 mRNA CTD PMID:17562736 Slc6a8 Mouse paracetamol increases expression ISO SLC6A8 (Homo sapiens) 6480464 Acetaminophen results in increased expression of SLC6A8 mRNA CTD PMID:29067470 Slc6a8 Mouse paracetamol decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC6A8 mRNA CTD PMID:22230336 Slc6a8 Mouse PCB138 decreases expression ISO Slc6a8 (Rattus norvegicus) 6480464 2 more ... CTD PMID:23829299 Slc6a8 Mouse pentanal increases expression ISO SLC6A8 (Homo sapiens) 6480464 pentanal results in increased expression of SLC6A8 mRNA CTD PMID:26079696 Slc6a8 Mouse perfluorononanoic acid decreases expression ISO SLC6A8 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of SLC6A8 mRNA CTD PMID:32588087 Slc6a8 Mouse perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC6A8 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SLC6A8 mRNA CTD PMID:36331819 Slc6a8 Mouse phenylmercury acetate decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of SLC6A8 mRNA CTD PMID:26272509 Slc6a8 Mouse phenylmercury acetate multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 Slc6a8 Mouse pirinixic acid decreases expression ISO Slc6a8 (Rattus norvegicus) 6480464 pirinixic acid results in decreased expression of SLC6A8 mRNA CTD PMID:19162173 Slc6a8 Mouse piroxicam multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of SLC6A8 mRNA CTD PMID:21858171 Slc6a8 Mouse potassium chromate increases expression ISO SLC6A8 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of SLC6A8 mRNA CTD PMID:22079256 Slc6a8 Mouse potassium chromate multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC6A8 mRNA CTD PMID:22079256 Slc6a8 Mouse propanal increases expression ISO SLC6A8 (Homo sapiens) 6480464 propionaldehyde results in increased expression of SLC6A8 mRNA CTD PMID:26079696 Slc6a8 Mouse quercetin decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Quercetin results in decreased expression of SLC6A8 mRNA CTD PMID:21632981 Slc6a8 Mouse resorcinol increases expression ISO SLC6A8 (Homo sapiens) 6480464 resorcinol results in increased expression of SLC6A8 mRNA CTD PMID:22623647 Slc6a8 Mouse rotenone increases expression ISO Slc6a8 (Rattus norvegicus) 6480464 Rotenone results in increased expression of SLC6A8 mRNA CTD PMID:19013527 and PMID:28374803 Slc6a8 Mouse SB 431542 multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Slc6a8 Mouse selenium atom increases expression ISO SLC6A8 (Homo sapiens) 6480464 Selenium results in increased expression of SLC6A8 mRNA CTD PMID:19244175 Slc6a8 Mouse silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of SLC6A8 mRNA CTD PMID:23221170 and PMID:29203145 Slc6a8 Mouse sodium arsenate multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC6A8 mRNA CTD PMID:32525701 Slc6a8 Mouse sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of SLC6A8 mRNA CTD PMID:31558096 Slc6a8 Mouse sunitinib increases expression ISO SLC6A8 (Homo sapiens) 6480464 Sunitinib results in increased expression of SLC6A8 mRNA CTD PMID:31533062 Slc6a8 Mouse tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of SLC6A8 mRNA CTD PMID:25123088 Slc6a8 Mouse tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of SLC6A8 mRNA CTD PMID:17484886 Slc6a8 Mouse tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC6A8 mRNA CTD PMID:31919559 Slc6a8 Mouse toluene affects expression ISO Slc6a8 (Rattus norvegicus) 6480464 Toluene affects the expression of SLC6A8 mRNA CTD PMID:18653662 Slc6a8 Mouse trichostatin A decreases expression ISO SLC6A8 (Homo sapiens) 6480464 trichostatin A results in decreased expression of SLC6A8 mRNA CTD PMID:24935251 and PMID:26272509 Slc6a8 Mouse trichostatin A multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 Slc6a8 Mouse trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of SLC6A8 mRNA CTD PMID:19042947 Slc6a8 Mouse triphenyl phosphate affects expression ISO SLC6A8 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of SLC6A8 mRNA CTD PMID:37042841 Slc6a8 Mouse urethane increases expression ISO SLC6A8 (Homo sapiens) 6480464 Urethane results in increased expression of SLC6A8 mRNA CTD PMID:28818685 Slc6a8 Mouse valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of SLC6A8 mRNA CTD PMID:17292431 Slc6a8 Mouse valproic acid multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 Slc6a8 Mouse valproic acid decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SLC6A8 mRNA CTD PMID:23179753 more ... Slc6a8 Mouse valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of SLC6A8 mRNA CTD PMID:20546886 Slc6a8 Mouse valproic acid increases methylation ISO SLC6A8 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of SLC6A8 gene CTD PMID:29154799 Slc6a8 Mouse valproic acid increases expression ISO SLC6A8 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC6A8 mRNA CTD PMID:23179753 Slc6a8 Mouse vitamin E increases expression ISO SLC6A8 (Homo sapiens) 6480464 Vitamin E results in increased expression of SLC6A8 mRNA CTD PMID:19244175 Slc6a8 Mouse vorinostat decreases expression ISO SLC6A8 (Homo sapiens) 6480464 vorinostat results in decreased expression of SLC6A8 mRNA CTD PMID:26272509 and PMID:27188386 Slc6a8 Mouse vorinostat multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 Slc6a8 Mouse zidovudine decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Zidovudine results in decreased expression of SLC6A8 mRNA CTD PMID:24292225 Slc6a8 Mouse zoledronic acid decreases expression ISO SLC6A8 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of SLC6A8 mRNA CTD PMID:24714768